Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Metastatic Melanoma Locally Advanced Refractory/Recurrent Melanoma Metastatic Head and Neck Cancer Locally Advanced Refractory/Recurrent Head and Neck Cancer melanoma metastatic head and neck cancer solid tumor adoptive cell therapy autologous IL-2 Head and Neck Neoplasms Interleukin-2 Autologous Tumor Infiltrating Lymphocytes High-Dose Interleukin 2
Lead Scientists at UC Cancer
- Gregory Daniels, MD, PhD (ucsd)
Dr. Daniels coordinates our clinical program in melanoma. His own research involves understanding the link between autoimmunity and tumor immunity in developing more effective and less toxic vaccines and immune stimulatory approaches for patients with melanoma.
- Ezra Cohen, MD (ucsd)
Professor, Medicine. Authored (or co-authored) 191 research publications.
- accepting new patients
- Start Date
- Completion Date
- Gregory Daniels
- Phase 1
- Study Type
- Last Updated